Oxygen sensing, cardiac ischemia, HIF-1α and some emerging concepts

Current Cardiology Reviews

Volumn 6, Issue 4, 2010, Pages 265-273

  Goswami, Shyamal K ^a   Das, Dipak K ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac ischemia; HIF 1; Hypoxia; Oxygen sensing; Preconditioning; Prolyl hydroxylase

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ARTICLE; BIOCHEMISTRY; CARCINOGENESIS; CARDIOVASCULAR SYSTEM; ELECTRON TRANSPORT; GENETICS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HUMAN; ISCHEMIC PRECONDITIONING; KNOWLEDGE; MAMMAL; MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SENSING; OXYGEN SUPPLY; OXYGEN TRANSPORT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN FUNCTION; STROKE; TISSUE OXYGENATION;

EID: 78651277564     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310793566136     Document Type: Article

References (145)

1. Kulkarni AC, Kuppusamy P, Parinandi N. Oxygen, the lead actorin the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy. AntioxidRedox Signal 2007; 9: 1717-30.
2. Brahimi-Horn MC, Pouyssegur J. Oxygen, a source of life andstress. FEBS Lett 2007; 581(19): 3582-91.
3. Mukherjee A, Brinkley DW, Chang KM, Roth JP. Molecular oxygendependent steps in fatty acid oxidation by cyclooxygenase-1. Biochemistry 2007; 46: 3975-89.
4. Boullier A, Maziere JC, Filipe P, et al. Interplay of oxygen, vitaminE, and carotenoids in radical reactions following oxidation ofTrp and Tyr residues in native HDL3 apolipoproteins. Comparisonwith LDL. A time-resolved spectroscopic analysis. Biochemistry 2007; 46: 5226-37.
5. Gao YT, Roman LJ, Martásek P, Panda SP, Ishimura Y, Masters BS. Oxygen Metabolism by Endothelial Nitric-oxide Synthase. JBiol Chem 2007; 282(39): 28557-65.
6. Palmer AE, Quintanar L, Severance S, Wang TP, Kosman DJ, Solomon EI. Spectroscopic characterization and O2 reactivity ofthe trinuclear Cu cluster of mutants of the multicopper oxidaseFet3p. Biochemistry 2002; 41: 6438-48.
7. Chandel NS, Budinger GR. The cellular basis for diverse responsesto oxygen. Free Radic Biol Med 2007; 42: 165-74.
8. Kulkarni AC, Kuppusamy P, Parinandi N. Oxygen, the lead actorin the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy. AntioxidRedox Signal 2007; 9: 1717-30.
9. Dyson A, Stidwill R, Taylor V, Singer M. Tissue oxygen monitoringin rodent models of shock. Am J Physiol Heart Circ Physiol 2007; 293: H526-33.
10. Vikram DS, Zweier JL, Kuppusamy P. Methods for noninvasiveimaging of tissue hypoxia. Antioxid Redox Signal 2007; 9: 1745-56.
11. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001; 93: 266-76.
12. Wyatt CN, Mustard KJ, Pearson SA, et al. AMP-activated proteinkinase mediates carotid body excitation by hypoxia. J Biol Chem 2007; 282: 8092-8.
13. Nauseef WM. Acute oxygen-sensing mechanisms. N Engl J Med 2006; 354(9): 975-7.
14. Acker T, Fandrey J, Acker H. The good, the bad and the ugly inoxygen-sensing: ROS, cytochromes and prolyl-hydroxylases. CardiovascRes 2006; 71(2): 195-207.
15. Kumar P. Sensing hypoxia in the carotid body: from stimulus toresponse. Essays Biochem 2007; 43: 43-60.
16. Moudgil R, Michelakis ED, Archer SL. The role of k+ channels indetermining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstrictionand pulmonary arterial hypertension. Microcirculation 2006; 13: 615-32.
17. Kemp PJ, Peers C. Oxygen sensing by ion channels. Essays Biochem 2007; 43: 77-90.
18. Hong Z, Hong F, Olschewski A, Cabrera JA, Varghese A, Nelson DP, Weir EK. Role of store-operated calcium channels and calciumsensitization in normoxic contraction of the ductus arteriosus. Circulation 2006; 114: 1372-9.
19. Kemp PJ, Williams SE, Mason HS, et al. Functional proteomics ofBK potassium channels: defining the acute oxygen sensor. NovartisFound Symp 2006; 272: 141-51.
20. Kemp PJ, Detecting acute changes in oxygen: will the real sensorplease stand up? Exp Physiol 2006; 91: 829-34.
21. Hool LC. Acute hypoxia differentially regulates K(+) channels. Implications with respect to cardiac arrhythmia. Eur Biophys J 2005; 34: 369-76.
22. Essop MF. Cardiac metabolic adaptations in response to chronichypoxia. J Physiol 2007; 584: 715-26.
23. Sen CK, Khanna S, Roy S. Perceived hyperoxia: oxygen-inducedremodeling of the reoxygenated heart. Cardiovasc Res 2006; 71: 280-8.
24. Deussen A, Brand M, Pexa A, Weichsel J. Metabolic coronaryflow regulation--current concepts. Basic Res Cardiol 2006; 101: 453-64.
25. Merkus D, Chilian WM, Stepp DW. Functional characteristics ofthe coronary microcirculation. Herz 1999; 24: 496-508.
26. Wilson DF, Erecińska M. The oxygen dependence of cellular energymetabolism. Adv Exp Med Biol 1986; 194: 229-39.
27. Rumsey WL, Schlosser C, Nuutinen EM, Robiolio M, Wilson DF. Cellular energetics and the oxygen dependence of respiration incardiac myocytes isolated from adult rat. J Biol Chem 1990; 265: 15392-402.
28. Kerkhof CJ, Van Der Linden PJ, Sipkema P. Role of myocardiumand endothelium in coronary vascular smooth muscle responses tohypoxia. Am J Physiol Heart Circ Physiol 2002; 282: H1296-303.
29. Tune JD, Gorman MW, Feigl EO. Matching coronary blood flowto myocardial oxygen consumption. J Appl Physiol 2004; 97: 404-15.
30. Hong TT, Huang J, Barrett TD, Lucchesi BR. Effects of cyclooxygenaseinhibition on canine coronary artery blood flow and thrombosis. Am J Physiol Heart Circ Physiol 2008; 294: H145-55.
31. Heintz A, Damm M, Brand M, Koch T, Deussen A. Coronary flowregulation in mouse heart during hypercapnic acidosis: role of NOand its compensation during eNOS impairment. Cardiovasc Res 2008; 77: 188-96.
32. Phillis JW, Song D, O'Regan MH. The role of adenosine in ratcoronary flow regulation during respiratory and metabolic acidosis. Eur J Pharmacol 1998; 356: 199-206.
33. Kupriyanov VV, Nighswander-Rempel S, Xiang B. Mapping regionaloxygenation and flow in pig hearts in vivo using nearinfraredspectroscopic imaging. J Mol Cell Cardiol 2004; 37: 947-57.
34. Bärtsch P, Gibbs JS. Effect of altitude on the heart and the lungs. Circulation 2007; 116: 2191-202.
35. McLeod CJ, Pagel I, Sack MN. The mitochondrial biogenesisregulatory program in cardiac adaptation to ischemia--a putativetarget for therapeutic intervention. Trends Cardiovasc Med 2005; 15: 118-23.
36. Zong P, Tune JD, Downey HF, Mechanisms of oxygen demand/supply balance in the right ventricle. Exp Biol Med(Maywood) 2005; 230(8): 507-19.
37. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. JClin Invest 2005; 115: 500-8.
38. Kreutzer U, Mekhamer Y, Chung Y, Jue T. Oxygen supply andoxidative phosphorylation limitation in rat myocardium in situ. AmJ Physiol Heart Circ Physiol 2001; 280: H2030-7.
39. Thuerauf DJ, Marcinko M, Gude N, Rubio M, Sussman MA, Glembotski CC. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. CircRes 2006; 99: 275-82.
40. Terai K, Hiramoto Y, Masaki M, et al. AMP-activated proteinkinase protects cardiomyocytes against hypoxic injury through attenuationof endoplasmic reticulum stress. Mol Cell Biol 2005; 25: 9554-75.
41. Shao Z, Bhattacharya K, Hsich E, et al. c-Jun N-terminal kinasesmediate reactivation of Akt and cardiomyocyte survival after hypoxicinjury in vitro and in vivo. Circ Res 2006; 98: 7-9.
42. Pfeil U, Paddenberg R, Kummer W. Mitochondrial regulation ofhypoxia-induced increase of adrenomedullin mRNA in HL-1 cells. Biochem Biophys Res Commun 2006; 343: 885-92.
43. Gálvez AS, Brunskill EW, Marreez Y, Benner BJ, Regula KM, Kirschenbaum LA. Dorn GW 2nd, Distinct pathways regulateproapoptotic Nix and BNip3 in cardiac stress. J Biol Chem 2006; 281: 1442-8.
44. Xu D, Patten RD, Force T, Kyriakis JM. Gene 33/RALT is inducedby hypoxia in cardiomyocytes, where it promotes cell death bysuppressing phosphatidylinositol 3-kinase and extracellular signalregulatedkinase survival signaling. Mol Cell Biol 2006; 26: 5043-54.
45. Han F, Takeda K, Yokoyama S, et al. Dynamic changes in expressionof heme oxygenases in mouse heart and liver during hypoxia. Biochem Biophys Res Commun 2005; 338: 653-9.
46. Karar J, Dolt KS, Mishra MK, Arif E, Javed S, Pasha MA. Expressionand functional activity of pro-oxidants and antioxidants inmurine heart exposed to acute hypobaric hypoxia. FEBS Lett 2007; 581: 4577-82.
47. Yeung HM, Kravtsov GM, Ng KM, Wong TM, Fung M. Chronicintermittent hypoxia alters Ca2+ handling in rat cardiomyocytes byaugmented Na+/Ca2+ exchange and ryanodine receptor activitiesin ischemia-reperfusion. Am J Physiol Cell Physiol 2007; 292: C2046-56.
48. Ramond A, Ribuot C, Lévy P, Joyeux-Faure M. Deleterious myocardialconsequences induced by intermittent hypoxia are reversedby erythropoietin. Respir Physiol Neurobiol 2007; 156: 362-9.
49. Guerra MS, Roncon-Albuquerque R Jr, Lourenço AP, et al. Remotemyocardium gene expression after 30 and 120 min ofischaemia in the rat. Exp Physiol 2006; 91(2): 473-80.
50. Frazier DP, Wilson A, Dougherty CJ, Li H, Bishopric NH, Webster KA. PKC-alpha and TAK-1 are intermediates in the activation of c-Jun NH2-terminal kinase by hypoxia-reoxygenation. Am J PhysiolHeart Circ Physiol 2007; 292: H1675-684.
51. Caretti A, Morel S, Milano G, et al. Heart HIF-1alpha and MAPkinases during hypoxia: are they associated in vivo? Exp Biol Med(Maywood) 2007; 232: 887-894.
52. Lahiri S. Historical perspectives of cellular oxygen sensing andresponses to hypoxia. J Appl Physiol 2000; 88: 1467-73.
53. Sugano T, Oshino N, Chance B. Mitochondrial functions underhypoxic conditions: The steady states of cytochrome c reductionand of energy metabolism. Biochim Biophys Acta (BBA) 1974; 347: 340-58.
54. Wilson DF, Rumsey WL. Factors modulating the oxygen dependenceof mitochondrial oxidative phosphorylation. Adv Exp MedBiol 1988; 222: 121-31.
55. Tan CC, Ratcliffe PJ. Effect of inhibitors of oxidative phosphorylationon erythropoietin mRNA in isolated perfused rat kidneys. AmJ Physiol 1991; 261: F982-87.
56. Chandel NS, Budinger GR, Schumacker PT. Molecular oxygenmodulates cytochrome c oxidase function. J Biol Chem 1996; 271: 18672-7.
57. Chandel NS, Budinger GR, Choe SH, Schumacker PT. Cellularrespiration during hypoxia. Role of cytochrome oxidase as theoxygen sensor in hepatocytes. J Biol Chem 1997; 272: 18808-16.
58. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription, Proc Natl Acad Sci U S A. 1998; 95: 11715-20.
59. Kwast KE, Burke PV, Staahl BT, Poyton RO. Oxygen sensing inyeast: evidence for the involvement of the respiratory chain inregulating the transcription of a subset of hypoxic genes. Proc NatlAcad Sci USA 1999; 96: 5446-51.
60. Guzy RD, Mack MM, Schumacker PT. Mitochondrial complex IIIis required for hypoxia-induced ROS production and gene transcriptionin yeast. Antioxid Redox Signal 2007; 9(9): 1317-28.
61. Vaux EC, Metzen E, Yeates KM, Ratcliffe PJ. Regulation of hypoxia-inducible factor is preserved in the absence of a functioningmitochondrial respiratory chain. Blood 2001; 98: 296-302.
62. Srinivas V, Leshchinsky I, Sang N, King MP, Minchenko A, Caro J. Oxygen sensing and HIF-1 activation does not require an activemitochondrial respiratory chain electron-transfer pathway. J BiolChem 2001; 276: 21995-8.
63. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria atcomplex III: the paradox of increased reactive oxygen species duringhypoxia. Exp Physiol 2006; 91: 807-19.
64. Moldovan L, Moldovan NI. Histochem Oxygen free radicals andredox biology of organelles. Cell Biol 2004; 122: 395-412.
65. Churchill EN, Szweda LI. Translocation of deltaPKC to mitochondriaduring cardiac reperfusion enhances superoxide anion productionand induces loss in mitochondrial function. Arch BiochemBiophys 2005; 439: 194-9.
66. Prabu SK, Anandatheerthavarada HK, Raza H, Srinivasan S, Spear JF, Avadhani NG. Protein kinase A-mediated phosphorylationmodulates cytochrome c oxidase function and augments hypoxiaand myocardial ischemia-related injury. J Biol Chem 2006; 281: 2061-70.
67. Adam-Vizi V, Chinopoulos C. Bioenergetics and the formation ofmitochondrial reactive oxygen species. Trends Pharmacol Sci 2006; 27: 639-45.
68. Lambeth JD. Nox enzymes, ROS, and chronic disease: an exampleof antagonistic pleiotropy. Free Radic Biol Med 2007; 43: 332-47.
69. Chen YR, Chen CL, Pfeiffer DR, Zweier JL. Mitochondrial complexII in the post-ischemic heart: oxidative injury and the role ofprotein S-glutathionylation. J Biol Chem 2007; 282: 32640-54.
70. Tompkins AJ, Burwell LS, Digerness SB, Zaragoza C, Holman WL, Brookes PS. Mitochondrial dysfunction in cardiac ischemiareperfusioninjury: ROS from complex I, without inhibition. BiochimBiophys Acta 2006; 1762: 223-31.
71. Redout EM, Wagner MJ, Zuidwijk MJ, et al. Right-ventricularfailure is associated with increased mitochondrial complex II activityand production of reactive oxygen species. Cardiovasc Res 2007; 75: 770-81.
72. Colom B, Oliver J, Roca P, Garcia-Palmer FJ. Caloric restrictionand gender modulate cardiac muscle mitochondrial H2O2 productionand oxidative damage. Cardiovasc Res 2007; 74: 456-65.
73. Schriner SE, Linford NJ, Martin GM, et al. Extension of murinelife span by overexpression of catalase targeted to mitochondria. Science 2005; 308: 1909-11.
74. Gordan JD, Simon MC. Hypoxia-inducible factors: central regulatorsof the tumor phenotype. Curr Opin Genet Dev 2007; 17: 71-77.
75. Coleman ML, Ratcliffe PJ. Oxygen sensing and hypoxia-inducedresponses. Essays Biochem 2007; 43: 1-15.
76. Rocha S. Gene regulation under low oxygen: holding your breathfor transcription. Trends Biochem Sci 2007; 32: 389-97.
77. Wang GL, Semenza GL. General involvement of hypoxiainduciblefactor 1 in transcriptional response to hypoxia. Proc NatlAcad Sci U S A 1993; 90: 4304-8.
78. Wang GL, Semenza GL. Characterization of hypoxia-induciblefactor 1 and regulation of DNA binding activity by hypoxia. J BiolChem 1993; 268: 21513-8.
79. Semenza GL, Oxygen-dependent regulation of mitochondrial respirationby hypoxia-inducible factor 1. Biochem J 2007; 405: 1-9.
80. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signalingat the consensus HRE. Sci STKE. 2005; re12.
81. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A. 1998; 95: 11715-20.
82. Chandel NS, McClintock DS, Feliciano CE, et al. Reactive oxygenspecies generated at mitochondrial complex III stabilize hypoxiainduciblefactor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 2000; 275: 25130-8.
83. Haddad JJ, Land SC. A non-hypoxic, ROS-sensitive pathway mediatesTNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett 2001; 505: 269-74.
84. Enomoto N, Koshikawa N, Gassmann M, Hayashi J, Takenaga K. Hypoxic induction of hypoxia-inducible factor-1alpha and oxygenregulatedgene expression in mitochondrial DNA-depleted HeLacells. Biochem Biophys Res Commun 2002; 297: 346-52.
85. Dada LA, Chandel NS, Ridge KM, Pedemonte C, Bertorello AM, Sznajder JI. Hypoxia-induced endocytosis of Na, K-ATPase in alveolarepithelial cells is mediated by mitochondrial reactive oxygenspecies and PKC-zeta. J Clin Invest 2003; 111(7): 1057-64.
86. Sanjuan-Pla A, Cervera AM, Apostolova N, et al. A targeted antioxidantreveals the importance of mitochondrial reactive oxygenspecies in the hypoxic signaling of HIF-1alpha. FEBS Lett 2005; 579: 2669-74.
87. Mansfield KD, Guzy RD, Pan Y, et al. Mitochondrial dysfunctionresulting from loss of cytochrome c impairs cellular oxygen sensingand hypoxic HIF-alpha activation. Cell Metab 2005; 1: 393-9.
88. Brunelle JK, Bell EL, Quesada NM, et al. Oxygen sensing requiresmitochondrial ROS but not oxidative phosphorylation. Cell Metab 2005; 1: 409-14.
89. Guzy RD, Hoyos B, Robin E, et al. Mitochondrial complex III isrequired for hypoxia-induced ROS production and cellular oxygensensing. Cell Metab 2005; 1: 401-8.
90. Kaelin WG Jr. ROS: really involved in oxygen sensing. Cell Metab 2005; 1: 357-8.
91. Collier J, Vallance P. Second messenger role for NO widens tonervous and immune systems. Trends Pharmacol Sci 1989; 10: 427-31.
92. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite:the good, the bad, and ugly. Am J Physiol 1996; 271: C1424-37.
93. Suzuki YJ, Forman HJ, Sevanian A, Oxidants as stimulators ofsignal transduction, Free Radic Biol Med 1997; 22: 269-285.
94. Palmer HJ, Paulson KE. Reactive oxygen species and antioxidantsin signal transduction and gene expression. Nutr Rev 1997; 55: 353-61.
95. D'Autreaux B, Toledano MB. ROS as signalling molecules:mechanisms that generate specificity in ROS homeostasis. Nat RevMol Cell Biol 2007; 8(10): 813-824.
96. Giorgio M, Trinei M, Migliaccio E, Pelicci PG. Hydrogen peroxide:a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 2007; 8: 722-8.
97. Fialkow L, Wang Y, Downey GP. Reactive oxygen and nitrogenspecies as signaling molecules regulating neutrophil function. FreeRadic Biol Med 2007; 42: 153-64.
98. Brigelius-Flohé R. Glutathione peroxidases and redox-regulatedtranscription factors. Biol Chem 2006; 387: 1329-35.
99. Fandrey J, Gorr TA, Gassmann M. Regulating cellular oxygensensing by hydroxylation, Cardiovasc Res 2006; 71: 642-51.
100. Berra E, Ginouves A, Pouyssegur J. The hypoxia-inducible-factorhydroxylases bring fresh air into hypoxia signaling. EMBO Rep 2006; 7: 41-45.
101. Simon MC. Mitochondrial reactive oxygen species are required forhypoxic HIF alpha stabilization. Adv Exp Med Biol 2006; 588: 165-70.
102. Turrens JF. Mitochondrial formation of reactive oxygen species. JPhysiol 2003; 552: 335-44.
103. Goswami SK, Maulik N, Das DK. Ischemia-reperfusion and cardioprotection:a delicate balance between reactive oxygen speciesgeneration and redox homeostasis. Ann Med 2007; 39: 275-89.
104. Shohet RV, Garcia JA. Keeping the engine primed: HIF factors askey regulators of cardiac metabolism and angiogenesis duringischemia. J Mol Med 2007; 85: 1309-15.
105. Qutub AA, Popel AS. Three autocrine feedback loops determineHIF1alpha expression in chronic hypoxia. Biochim Biophys Acta 2007; 1773: 1511-25.
106. Caretti A, Morel S, Milano G, et al. Heart HIF-1alpha and MAPkinases during hypoxia: are they associated in vivo? Exp Biol Med(Maywood) 2007; 232: 887-94.
107. Sano M, Minamino T, Toko H, et al. 53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007; 446: 444-8.
108. Kamat CD, Thorpe JE, Shenoy SS, et al. A long-term "memory" ofHIF induction in response to chronic mild decreased oxygen afteroxygen normalization. BMC Cardiovasc Disord 2007; 7-4.
109. Zampino M, Yuzhakova M, Hansen J, et al. Sex-related dimorphicresponse of HIF-1 alpha expression in myocardial ischemia. Am JPhysiol Heart Circ Physiol 2006; 291: H957-64.
110. Jung F, Palmer LA, Zhou N, Johns RA. Hypoxic regulation ofinducible nitric oxide synthase via hypoxia inducible factor-1 incardiac myocytes. Circ Res 2000; 86: 319-25.
111. Ladoux A, Frelin C. Cardiac expressions of HIF-1 alpha andHLF/EPAS, two basic loop helix/PAS domain transcription factorsinvolved in adaptative responses to hypoxic stresses. BiochemBiophys Res Commun 1997; 240: 552-6.
112. Bianciardi P, Fantacci M, Caretti A, et al. Chronic in vivo hypoxiain various organs: hypoxia-inducible factor-1alpha and apoptosis. Biochem Biophys Res Commun 2006; 342: 875-80.
113. Willam C, Maxwell PH, Nichols L, et al. HIF prolyl hydroxylasesin the rat; organ distribution and changes in expression followinghypoxia and coronary artery ligation. J Mol Cell Cardiol 2006; 41: 68-77.
114. Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactatetransporter MCT4, but not MCT1, is up-regulated by hypoxiathrough a HIF-1alpha-dependent mechanism. J Biol Chem 2006; 281: 9030-7.
115. Weidemann A, Klanke B, Wagner M, et al. Hypoxia, via stabilizationof hypoxia-inducible factor HIF-1alpha is a direct and sufficientstimulus for brain-type natriuretic peptide induction. BiochemJ 2008; 409: 233-42.
116. Dai Y, Xu M, Wang Y, Pasha Z, Li T, Ashraf M. HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protectscardiomyocytes against ischemia. J Mol Cell Cardiol 2007; 42: 1036-44.
117. Ronkainen VP, Ronkainen JJ, Hänninen SL, et al. Hypoxia induciblefactor regulates the cardiac expression and secretion of apelin. FASEB J 2007; 2: 1821-30.
118. Qutub AA, Popel AS. A computational model of intracellular oxygensensing by hypoxia-inducible factor HIF1 alpha. J Cell Sci 2006; 119: 3467-80.
119. Feng W, Wang Y, Cai L, Kang YJ. Metallothionein rescues hypoxia-inducible factor-1 transcriptional activity in cardiomyocytesunder diabetic conditions. Biochem Biophys Res Commun 2007; 360: 286-9.
120. Willam C, Maxwell PH, Nichols L, et al. Pugh CW HIF prolylhydroxylases in the rat; organ distribution and changes in expressionfollowing hypoxia and coronary artery ligation. J Mol CellCardiol 2006; 41: 68-77.
121. Sano M, Minamino T, Toko H, et al. 53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007; 446: 444-8.
122. Kakinuma Y, Ando M, Kuwabara M, et al. Acetylcholine fromvagal stimulation protects cardiomyocytes against ischemia andhypoxia involving additive non-hypoxic induction of HIF-1alpha. FEBS Lett 2005; 579: 2111-8.
123. Muinck ED, Nagy N, Tirziu D, et al. Protection against myocardialischemia-reperfusion injury by the angiogenic Masterswitch proteinPR 39 gene therapy: the roles of HIF1alpha stabilization andFGFR1 signaling. Antioxid Redox Signal 2007; 9: 437-45.
124. Kido M, Du L, Sullivan CC, et al. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunctionafter myocardial infarction in the mouse. J Am Coll Cardiol 2005; 46: 2116-24.
125. Natarajan R, Salloum FN, Fisher BJ, Ownby ED, Kukreja RC, Fowler AA. 3rd, Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatoryresponses in postischemic myocardium. Am J Physiol Heart CircPhysiol 2007; 293: H1571-80.
126. Das DK, Maulik N. Preconditioning potentiates redox signalingand converts death signal into survival signal. Arch Biochem Biophys 2003; 420: 305-11.
127. Malik G, Nagy N, Ho YS, Maulik N, Das DK. Role of glutaredoxin-1 in cardioprotection: An insight with Glrx1 transgenic andknockout animals. J Mol Cell Cardiol 2008; 44(2): 261-9.
128. Turoczi T, Jun L, Cordis G, et al. HFE mutation and dietary ironcontent interact to increase ischemia/reperfusion injury of the heartin mice. Circ Res 2003; 92: 1240-6.
129. Brady NR, Hamacher-Brady A, Westerhoff HV, Gottlieb RA. Awave of reactive oxygen species (ROS)-induced ROS release in asea of excitable mitochondria. Antioxid Redox Signal 2006; 8: 1651-65.
130. Das S, Engelman RM, Maulik N, Das DK. Angiotensin preconditioningof the heart: evidence for redox signaling. Cell BiochemBiophys 2006; 44: 103-10.
131. Berndt C, Lillig CH, Holmgren A. Thiol-based mechanisms of thethioredoxin and glutaredoxin systems: implications for diseases inthe cardiovascular system. Am J Physiol Heart Circ Physiol 2007; 292: H1227-36.
132. Kobayashi-Miura M, Shioji K, Hoshino Y, Masutani H, Nakamura H, Yodoi J. Oxygen sensing and redox signaling: the role of thioredoxinin embryonic development and cardiac diseases. Am JPhysiol Heart Circ Physiol 2007; 292: H2040-50.
133. Hurd TR, Costa NJ, Dahm CC, et al. Glutathionylation of mitochondrialproteins. Antioxid Redox Signal 2005; 7: 999-1010.
134. Conrad M, Jakupoglu C, Moreno SG, et al. Essential role for mitochondrialthioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 2004; 24: 9414-1423.
135. Welsh SJ, Bellamy WT, Briehl MM, Powis G. The redox proteinthioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alphaprotein expression: Trx-1 overexpression results in increased vascularendothelial growth factor production and enhanced tumor angiogenesis. Cancer Res 2002; 62: 5089-95.
136. Zhou J, Damdimopoulos AE, Spyrou G, et al. Thioredoxin 1 andthioredoxin 2 have opposed regulatory functions on hypoxiainduciblefactor-1alpha. J Biol Chem 2007; 282: 7482-90.
137. Das DK, Maulik N. Cardiac genomic response following preconditioningstimulus. Cardiovasc Res 2006; 70: 254-63.
138. Xi L, Taher M, Yin C, Salloum F, Kukreja RC. Cobalt chlorideinduces delayed cardiac preconditioning in mice through selectiveactivation of HIF-1alpha and AP-1 and iNOS signaling. Am JPhysiol Heart Circ Physiol 2004; 287(6): H2369-75.
139. Cai Z, Manalo DJ, Wei G, et al. Hearts from rodents exposed tointermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003; 108: 79-85.
140. Kawata H, Yoshida K, Kawamoto A, et al. Ischemic preconditioningupregulates vascular endothelial growth factor mRNA expressionand neovascularization via nuclear translocation of proteinkinase C epsilon in the rat ischemic myocardium. Circ Res 2001; 88: 696-704.
141. Chen WJ, Chen HW, Yu SL, et al. Gene expression profiles inhypoxic preconditioning using cDNA microarray analysis: alteredexpression of an angiogenic factor, carcinoembryonic antigenrelatedcell adhesion molecule. Shock 2005; 24: 124-31.
142. Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, Fong GH. Placentalbut not heart defects are associated with elevated hypoxiainduciblefactor alpha levels in mice lacking prolyl hydroxylasedomain protein 2. Mol Cell Biol 2006; 26: 8336-46.
143. Helton R, Cui J, Scheel JR, et al. Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci 2005; 25: 4099-107.
144. Köhl R, Zhou J, Brüne B. Reactive oxygen species attenuate nitricoxide-mediated hypoxia-inducible factor-1alpha stabilization. FreeRadic Biol Med 2006; 40: 1430-42.
145. Crozier SJ, Zhang X, Wang J, Cheung J, Kimball SR, Jefferson LS. Activation of signaling pathways and regulatory mechanisms ofmRNA translation following myocardial ischemia-reperfusion. JAppl Physiol 2006; 101: 576-82.